Description

The prevalence of anal dysplasia and human papillomavirus (HPV)–related anal cancer is on the rise. There is an increase in incidence in both high- and low-risk individuals without HIV, although the surveillance and management of anal dysplasia in high-risk groups have been extensively studied. Appropriate surveillance guidelines for low-risk patients with anal dysplasia are also not well defined. The purpose of this symposium is to review the current work-up and management of anal dysplasia and examine the recommended surveillance guidelines in high- and low-risk patients.

Moderator: Sanghyun (Alex) Kim, MD
Speaker: Julian Sanchez, MD

Credit Hours Available: 1.0 AMA PRA Category 1 Credit(s)™
Release Date: November 14, 2025
CME Expires: November 14, 2028